Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-10

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the effectiveness of medium frequency electrotherapy (interferential currents) treatment for overactive bladder (OAB), lower urinary tract symptoms (LUTS) and pelvic pain

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment

NCT03250650

Overactive Bladder Syndrome

COMPLETED NA

Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder

NCT03742206

Overactive Bladder Urinary Urge Incontinence

UNKNOWN NA

Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome

NCT03331081

Overactive Bladder Syndrome

UNKNOWN NA

Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder

NCT04450511

Urge Incontinence Episodes After the Magnetic Stimulation Added to Bladder Training in Women With Idiopathic Overactive Bladder

COMPLETED NA

Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB

NCT02657057

Overactive Bladder Urge Incontinence Overactive Detrusor

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study consists of 100 women, complaining of increased bladder sensation and urgency with or without incontinence as principal symptomatology and who had not received previous pharmacological treatment. Group-A was used as a control group (n = 50). Group-B patients received 18 sessions of medium frequency electrotherapy during 9 weeks, 2 weekly sessions

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Bladder, Overactive Lower Urinary Tract Symptoms Pelvic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Quasi-experimental, longitudinal, pre-/post-. Level of evidence II/III.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Type inclusion was consecutively type

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group-A

No treatment

Group Type PLACEBO_COMPARATOR

No treatment

Intervention Type OTHER

No treatment

Group-B

Medium frequency electrotherapy (interferential currents)

Group Type EXPERIMENTAL

Medium frequency electrotherapy (interferential currents)

Intervention Type OTHER

Treatment with medium frequency electrotherapy, interferential currents between 5500 Hz and 8500 Hz (Combi-200®, Gymna®), was performed using transvaginal application. The frequency was increased progressively over the first six sessions (twice a week), starting with a frequency of 5500 Hz until reaching a frequency of 8500 Hz, which remained until the end of treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medium frequency electrotherapy (interferential currents)

Treatment with medium frequency electrotherapy, interferential currents between 5500 Hz and 8500 Hz (Combi-200®, Gymna®), was performed using transvaginal application. The frequency was increased progressively over the first six sessions (twice a week), starting with a frequency of 5500 Hz until reaching a frequency of 8500 Hz, which remained until the end of treatment.

Intervention Type OTHER

No treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Increased bladder sensation Urgency Overactive bladder Lower urinary tract symptoms Pelvic pain

Exclusion Criteria

Neurogenic bladder Acute urinary infection Pelvic floor surgery Congenital urological malformations Age less than 18 years Bladder organic pathology Pelvic radiotherapy

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No